Can-Fite BioPharma CANF
NYSE CANF
$3.33 -0.02 (-0.60%)
At close: Aug 21, 2026 · 4:00 PM EDT

Can-Fite BioPharma (CANF) Long-Term Investments (2016 - 2019)

Can-Fite BioPharma's (CANF) quarterly Long-Term Investments came in at $1.6 million in Q4 2019, up 45.4% on a QoQ basis from $1.1 million in Q3 2018.

Can-Fite BioPharma (CANF) Long-Term Investments (2016 - 2019) Analysis & Trends

Can-Fite BioPharma (CANF) has 4 years of Long-Term Investments data on file, last reported at $1.6 million in Q4 2019.

  • Quarterly Long-Term Investments changed N/A year-over-year to $1.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $1.6 million (changed N/A YoY) and the FY2019 annual result came in at $1.6 million, changed N/A from the prior year.
  • Long-Term Investments climbed to $1.6 million in Q4 2019, from $1.1 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $1.8 million in Q2 2018 to a low of $564000.0 in Q4 2016.
  • A 4-year average of $1.1 million and a median of $1.0 million in 2018 frame the typical range for Long-Term Investments.
  • The widest YoY moves for Long-Term Investments: up 62.59% in 2017, down 62.59% in 2017.
  • Tracing CANF's Long-Term Investments over 4 years: stood at $564000.0 in 2016, then surged by 62.59% to $917000.0 in 2017, then advanced by 17.45% to $1.1 million in 2018, then jumped by 45.4% to $1.6 million in 2019.
  • The last three Long-Term Investments figures came in at $1.6 million (Q4 2019), $1.1 million (Q3 2018), and $1.8 million (Q2 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.77 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 22.17 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 372.10 Mn
10 Can-Fite BioPharma 2.76 Mn -8.79 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 1.57 Mn
Sep 30, 2018 1.08 Mn
Jun 30, 2018 1.83 Mn
Mar 31, 2018 927,000.00
Dec 31, 2017 917,000.00
Dec 31, 2016 564,000.00